2013 BDO Biotech Briefing

November 2013

The biotech industry is staying committed to its investment in research and development (R&D) according to BDO's 2013 Biotech Briefing, which examined the most recent 10K SEC filings of companies listed on the NASDAQ Biotechnology Index. In addition to R&D, the study analyzed employment, financing and capital market trends, including the significant impact the JOBS Act has had on the industry.